Biocontrol of Staphylococcus aureus in curd manufacturing processes using bacteriophages

被引:116
作者
Garcia, Pilar [1 ]
Madera, Carmen [1 ]
Martinez, Beatriz [1 ]
Rodriguez, Ana [1 ]
机构
[1] Inst Prod Lacteos Asturias, CSIC, E-33300 Villaviciosa, Spain
关键词
lytic phage; biocontrol; dairy products; Staphylococcus aureus;
D O I
10.1016/j.idairyj.2007.03.014
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The ability of specific bacteriophages to inhibit Staphylococcus aureus growth in curd manufacturing processes was determined. Two lytic bacteriophages specific against S. aureus were obtained by DNA random deletion from the milk-isolated temperate phages, Phi H5 and Phi A72. A cocktail of these lytic phages, 088 and 035, at multiplicity of infection (MOI) of 100, produced a complete elimination of 3 x 10(6) cfu mL(-1) of the pathogen in ultra-high-temperature (UHT) whole milk at 37 degrees C. Furthermore, the frequency of emergence of bacteriophage-insensitive mutants was reduced up to 200-fold in the presence of the two lytic phages compared with that detected with the combination of the temperate counterparts. The lytic phage derivatives, added to milk, were able to decrease rapidly the viable counts of S. aureus during curd manufacture. In acid curd, the pathogen was not detected after 4 h of incubation at 25 degrees C, whereas pathogen clearance was achieved within 1 h of incubation at 30 degrees C in renneted curd. These results indicate that lytic bacteriophages could be used as biopreservatives in the manufacture of particular dairy products. 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1232 / 1239
页数:8
相关论文
共 35 条
[1]   Bacteriophage observations and evolution [J].
Ackermann, HW .
RESEARCH IN MICROBIOLOGY, 2003, 154 (04) :245-251
[2]   Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium [J].
Biswas, B ;
Adhya, S ;
Washart, P ;
Paul, B ;
Trostel, AN ;
Powell, B ;
Carlton, R ;
Merril, CR .
INFECTION AND IMMUNITY, 2002, 70 (01) :204-210
[3]   Phages and the evolution of bacterial pathogens:: From genomic rearrangements to lysogenic conversion [J].
Brüssow, H ;
Canchaya, C ;
Hardt, WD .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2004, 68 (03) :560-+
[4]   Human volunteers receiving Escherichia coli phage T4 orally:: a safety test of phage therapy [J].
Bruttin, A ;
Brüssow, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :2874-2878
[5]   Comparative performance of a mixed strain starter in cow's milk, ewe's milk and mixtures of these milks [J].
Cárcoba, R ;
Delgado, T ;
Rodríguez, A .
EUROPEAN FOOD RESEARCH AND TECHNOLOGY, 2000, 211 (02) :141-146
[6]   Bacteriophage P100 for control of Listeria monocytogenes in foods:: Genome sequence, bioinformatic analyses, oral toxicity study, and application [J].
Carlton, RM ;
Noordman, WH ;
Biswas, B ;
de Meester, ED ;
Loessner, MJ .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2005, 43 (03) :301-312
[7]   Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice [J].
Cerveny, KE ;
DePaola, A ;
Duckworth, DH ;
Gulig, PA .
INFECTION AND IMMUNITY, 2002, 70 (11) :6251-6262
[8]   A STUDY OF THE MICROBIOLOGICAL STATUS OF IRISH FARMHOUSE CHEESES WITH EMPHASIS ON SELECTED PATHOGENIC AND SPOILAGE MICROORGANISMS [J].
COVENEY, HM ;
FITZGERALD, GF ;
DALY, C .
JOURNAL OF APPLIED BACTERIOLOGY, 1994, 77 (06) :621-630
[9]   Implication of milk and milk products in food-borne diseases in France and in different industrialised countries [J].
De Buyser, ML ;
Dufour, B ;
Maire, M ;
Lafarge, V .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2001, 67 (1-2) :1-17
[10]   Exotoxins of Staphylococcus aureus [J].
Dinges, MM ;
Orwin, PM ;
Schlievert, PM .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (01) :16-+